Ro5-3335 Acts as an Inhibitor of Core Binding Factor (CBF) Leukemia
Core binding factor (CBF) leukemias account for ∼24% of adult acute myeloid leukemia (AML) and 25% of pediatric acute lymphocytic leukemia (ALL). CBF leukemias show translocations or inversions that affect…